Back to search results

Telehealth Treatment for Opioid Use Disorder

This study is looking at how well a telehealth platform called RecoveryPad (RP) works for adults with moderate or severe opioid use disorder (OUD). RecoveryPad is a device designed to help you stay motivated and engaged in your treatment for OUD. To join, you need to be at least 18 years old, speak and write English, have a working cell phone or device with internet access, and have been diagnosed with moderate or severe OUD. The main goal is to see if using RecoveryPad helps people attend their medication for opioid use disorder (MOUD) appointments for up to 30 days. The current recruitment status is unclear.

Study design
This is an interventional study planning to enroll 470 participants. The study will assess the effects of the RecoveryPad platform.
What's involved
Not specified in the trial record.
Compensation
Not stated in the trial record.
Follow-up
The primary outcome is measured at up to 30 days.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT07362082

A Clinical Trial of Telehealth Treatment for Opioid Use Disorders

Not Yet Recruiting
NAAges 18+InterventionalTreatment
Yale University
~470 participants
Updated 2026-07-27 on ClinicalTrials.gov
What's tested:RecoveryPad platform

At a glance

Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Attendance for MOUD
Measured over Up to 30 days

Conditions

Opioid Use Disorder

Explore related trials

Opioid Use Disorder

Where it's being run

1 sites across 1 states
Connecticut1

Study leadership

  • Rebekah Heckmann, MD · PRINCIPAL_INVESTIGATOR · Yale University
  • Nasim Sabounchi, PhD · PRINCIPAL_INVESTIGATOR · CUNY Graduate School of Public Health & Health Policy

Who to contact

Rebekah Heckmann, MD
[email protected]
(203) 737-8335
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Can speak, read and write in English
Provision of signed and dated informed consent form
Screened positive for OUD, moderate or severe, based on the Diagnostic and Statistical Manual-5th Edition
Have a working cell phone number and working device that can access a web browser and receive texts (i.e., smartphone, tablet or computer)
Can provide a working email address OR be willing to create one

Exclusion

Current use of buprenorphine, methadone, or naltrexone for a substance use disorder
Pregnancy
Known current suicide risk based on participant self-report
On parole or incarcerated at time of enrollment based on participant self-report

What this trial measures

  • Attendance for MOUDUp to 30 days

    Overall attendance will be measured by attendance (yes or no) at the first MOUD appointment within 30 days of enrollment.